Jeffrey N. Simmons, PRESIDENT, CEO AND DIRECTOR at Elanco Animal Health Inc (ELAN), bought 4,971 shares at $20.09 ($100K) on 2026-05-15, disclosed to the SEC on 2026-05-19.
CEO Jeffrey N. Simmons purchased 4,971 shares for roughly $100k, marking the largest purchase of his career. This buyback occurs as the stock has retreated 20.1% over the last 90 days, potentially offering a value entry point.
ELAN is currently trading at $19.80, down 20.1% over the last 90 days and 28.57% below its 52-week high of $27.72.
Catalysts include the launch of Befrena on May 21, the Q1 2026 results that raised guidance on May 7, and the fact that this is the largest insider purchase of CEO Simmons' career.
Risks include a short interest of 7.75% and a May 19 report highlighting that the stock has underperformed the S&P 500 recently.
Something here stands out, but not much.
| Filing → |
| ELAN | BUY | 2023-03-13 | $144K | — | Filing → |
| ELAN | BUY | 2022-09-09 | $436K | — | Filing → |
| ELAN | BUY | 2021-08-11 | $500K | — | Filing → |